Guardian Pharmacy Services GRDN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $64.89M-1.1% | $65.62M+79.8% | $36.49M+93.9% | $18.82M— | —— | ||
| $111.7M+9.9% | $101.61M-4.3% | $106.19M+12.8% | $94.13M-3.4% | $97.41M+0.3% | ||
| $47.16M+8.8% | $43.36M-9.4% | $47.86M+8.4% | $44.16M— | —— | ||
| $235.18M+6.1% | $221.63M+11.8% | $198.28M+16.3% | $170.46M— | —— | ||
| $56.62M+2.0% | $55.52M-1.1% | $56.12M+3.1% | $54.43M— | —— | ||
| $79.74M0.0% | $79.74M+0.2% | $79.57M+4.5% | $76.16M— | —— | ||
| $17.48M-5.4% | $18.48M-2.3% | $18.92M+7.5% | $17.59M— | —— | ||
| $426.94M+3.5% | $412.66M+5.8% | $390.04M+9.5% | $356.33M— | —— | ||
| $451.42M+1.5% | $444.54M+3.2% | $430.75M+3.6% | $415.95M+32.0% | $315.11M+42.8% | ||
| $160.54M-0.1% | $160.7M-0.8% | $161.95M+12.5% | $143.99M— | —— | ||
| $194.52M-0.1% | $194.73M+0.1% | $194.54M+10.1% | $176.66M— | —— | ||
| $79.64M+20.0% | $66.34M+46.1% | $45.42M+27.6% | $35.6M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $426.94M+3.5% | $412.66M+5.8% | $390.04M+9.5% | $356.33M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardian Pharmacy Services's total assets?
- Guardian Pharmacy Services (GRDN) holds $426.9M in total assets, up 27.8% year over year.
- How much debt does Guardian Pharmacy Services have?
- Guardian Pharmacy Services carries $36.9M in total debt against $232.4M of shareholders' equity, a debt-to-equity ratio of 0.16.
- How much cash does Guardian Pharmacy Services have?
- Guardian Pharmacy Services holds $64.9M in cash and equivalents.
- Can Guardian Pharmacy Services cover its short-term obligations?
- Its current ratio is 1.46 — current assets exceed current liabilities.
- Where does Guardian Pharmacy Services's balance sheet data come from?
- Every line is extracted from Guardian Pharmacy Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
